Abstract
Secondary experimental procedures such as immunostaining have been utilized to study wild-type influenza A viruses (IAV) but are inadequate to rapidly determine the virus in infected cells or for the high-throughput screening (HTS) of antivirals or neutralizing antibodies. Reverse genetics approaches have allowed the generation of recombinant IAV expressing bioluminescent (BL) reporters or fluorescent proteins (FPs). These approaches can easily track viral infections in cultured cells and in validated animal models of infection using in vivo imaging systems (IVIS). Here, we describe the experimental procedures to generate recombinant monomeric (m)Cherry-expressing influenza A/Puerto Rico/8/34 (PR8-mCherry) H1N1 by altering the non-structural (NS) vRNA segment and its use in mCherry-based microneutralization assays to assess antivirals and neutralizing antibodies. The experimental procedures could be used for the generation of other recombinant influenza virus types (e.g., influenza B) or IAV subtypes (e.g., H3N2) expressing mCherry or other BL reporters or FPs from the NS or other vRNA segment. These recombinant reporter-expressing viruses represent an excellent toolbox for the identification of prophylactics or therapeutics for the treatment of influenza viral infections in HTS settings as well as to study different aspects related with the biology of influenza viruses and/or its interaction with the host.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Foni E, Chiapponi C, Baioni L et al (2017) Influenza D in Italy: towards a better understanding of an emerging viral infection in swine. Sci Rep 7(1):11660
Su S, Fu X, Li G et al (2017) Novel Influenza D virus: epidemiology, pathology, evolution and biological characteristics. Virulence 8(8):1580–1591
Asha K, Kumar B (2019) Emerging Influenza D virus threat: what we know so far! J Clin Med 8(2):192
Hengrung N, El Omari K, Serna Martin I et al (2015) Crystal structure of the RNA-dependent RNA polymerase from influenza C virus. Nature 527(7576):114–117
Nakatsu S, Murakami S, Shindo K et al (2018) Influenza C and D viruses package eight organized Ribonucleoprotein complexes. J Virol 92(6):e02084
Wang M, Ludwig K, Bottcher C et al (2016) The role of stearate attachment to the hemagglutinin-esterase-fusion glycoprotein HEF of influenza C virus. Cell Microbiol 18(5):692–704
Zhang W, Zhang L, He W et al (2019) Genetic evolution and molecular selection of the HE gene of Influenza C virus. Viruses 11(2):167
Chen R, Holmes EC (2008) The evolutionary dynamics of human influenza B virus. J Mol Evol 66(6):655–663
Wanitchang A, Narkpuk J, Jaru-ampornpan P et al (2012) Inhibition of influenza A virus replication by influenza B virus nucleoprotein: an insight into interference between influenza A and B viruses. Virology 432(1):194–203
Baker SF, Nogales A, Finch C et al (2014) Influenza A and B virus intertypic reassortment through compatible viral packaging signals. J Virol 88(18):10778–10791
Nogales A, Perez DR, Santos J et al (2017) Reverse genetics of Influenza B viruses. Methods Mol Biol 1602:205–238
Wright PF, Neumann G, Kawaoka Y (2007) Orthomyxoviruses. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA (eds) Fields Virology, 5th edn. Lippincott Williams and WIlkins
Tong S, Zhu X, Li Y et al (2013) New world bats harbor diverse influenza A viruses. PLoS Pathog 9(10):e1003657
Yoon SW, Webby RJ, Webster RG (2014) Evolution and ecology of influenza a viruses. Curr Top Microbiol Immunol 385:359–375
Matsuzaki Y, Sugawara K, Furuse Y et al (2016) Genetic lineage and reassortment of Influenza C viruses circulating between 1947 and 2014. J Virol 90(18):8251–8265
Paules CI, Sullivan SG, Subbarao K et al (2018) Chasing seasonal influenza - the need for a universal Influenza vaccine. N Engl J Med 378(1):7–9
Krammer F, Palese P, Steel J (2015) Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin. Curr Top Microbiol Immunol 386:301–321
Federici C, Cavazza M, Costa F et al (2018) Health care costs of influenza-related episodes in high income countries: a systematic review. PLoS One 13(9):e0202787
Raviotta JM, Smith KJ, DePasse J et al (2017) Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults. Vaccine 35(42):5708–5713
Parrish CR, Murcia PR, Holmes EC (2015) Influenza virus reservoirs and intermediate hosts: dogs, horses, and new possibilities for influenza virus exposure of humans. J Virol 89(6):2990–2994
Long JS, Mistry B, Haslam SM et al (2019) Host and viral determinants of influenza A virus species specificity. Nat Rev Microbiol 17(2):67–81
Mostafa A, Abdelwhab EM, Mettenleiter TC et al (2018) Zoonotic potential of Influenza A viruses: a comprehensive overview. Viruses 10(9):497
Neumann G, Noda T, Kawaoka Y (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459(7249):931–939
Louie JK, Jean C, Acosta M et al (2011) A review of adult mortality due to 2009 pandemic (H1N1) influenza A in California. PLoS One 6(4):e18221
Barr IG, McCauley J, Cox N et al (2010) Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season. Vaccine 28(5):1156–1167
Simonsen L, Reichert TA, Viboud C et al (2005) Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 165(3):265–272
McLean HQ, Peterson SH, King JP et al (2017) School absenteeism among school-aged children with medically attended acute viral respiratory illness during three influenza seasons, 2012-2013 through 2014-2015. Influenza Other Respir Viruses 11(3):220–229
Principi N, Esposito S (2017) Protection of children against influenza: emerging problems. Hum Vaccin Immunother 14:1–8
Falsey AR, Treanor JJ, Tornieporth N et al (2009) Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis 200(2):172–180
Fuller JD, Craven DE, Steger KA et al (1999) Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis 28(3):541–547
Carrat F, Flahault A (2007) Influenza vaccine: the challenge of antigenic drift. Vaccine 25(39–40):6852–6862
Doherty PC, Kelso A (2008) Toward a broadly protective influenza vaccine. J Clin Invest 118(10):3273–3275
Fiore AE, Uyeki TM, Broder K et al (2010) Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 59(RR-8):1–62
Nogales A, DeDiego ML, Topham DJ et al (2016) Rearrangement of Influenza virus spliced segments for the development of live-attenuated vaccines. J Virol 90(14):6291–6302
Pica N, Palese P (2013) Toward a universal influenza virus vaccine: prospects and challenges. Annu Rev Med 64:189–202
Palese PS, ML (2007) Orthomyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA (eds) Fields virology, 5th edn. Lippincott Williams and WIlkins
Martinez-Sobrido L, Peersen O, Nogales A (2018) Temperature sensitive mutations in Influenza A viral Ribonucleoprotein complex responsible for the attenuation of the live attenuated Influenza vaccine. Viruses 10(10):560
Nogales A, Martinez-Sobrido L (2016) Reverse genetics approaches for the development of Influenza vaccines. Int J Mol Sci 18(1):20
Neumann G, Brownlee GG, Fodor E et al (2004) Orthomyxovirus replication, transcription, and polyadenylation. Curr Top Microbiol Immunol 283:121–143
Boivin S, Cusack S, Ruigrok RW et al (2010) Influenza A virus polymerase: structural insights into replication and host adaptation mechanisms. J Biol Chem 285(37):28411–28417
Engelhardt OG (2013) Many ways to make an influenza virus--review of influenza virus reverse genetics methods. Influenza Other Respir Viruses 7(3):249–256
Fukuyama S, Katsura H, Zhao D et al (2015) Multi-spectral fluorescent reporter influenza viruses (Color-flu) as powerful tools for in vivo studies. Nat Commun 6:6600
Manicassamy B, Manicassamy S, Belicha-Villanueva A et al (2010) Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci U S A 107(25):11531–11536
Perez JT, Garcia-Sastre A, Manicassamy B (2013) Insertion of a GFP reporter gene in influenza virus. Curr Protoc Microbiol Chapter 15:Unit 15G 4
Reuther P, Gopfert K, Dudek AH et al (2015) Generation of a variety of stable Influenza A reporter viruses by genetic engineering of the NS gene segment. Sci Rep 5:11346
Tran V, Moser LA, Poole DS et al (2013) Highly sensitive real-time in vivo imaging of an influenza reporter virus reveals dynamics of replication and spread. J Virol 87(24):13321–13329
Tran V, Poole DS, Jeffery JJ et al (2015) Multi-modal imaging with a toolbox of Influenza A reporter viruses. Viruses 7(10):5319–5327
Breen M, Nogales A, Baker SF et al (2016) Replication-competent Influenza A viruses expressing reporter genes. Viruses 8(7):179
Nogales A, Baker SF, Martinez-Sobrido L (2014) Replication-competent influenza A viruses expressing a red fluorescent protein. Virology 476C:206–216
Avilov SV, Moisy D, Munier S et al (2012) Replication-competent influenza A virus that encodes a split-green fluorescent protein-tagged PB2 polymerase subunit allows live-cell imaging of the virus life cycle. J Virol 86(3):1433–1448
Eckert N, Wrensch F, Gartner S et al (2014) Influenza A virus encoding secreted Gaussia luciferase as useful tool to analyze viral replication and its inhibition by antiviral compounds and cellular proteins. PLoS One 9(5):e97695
Karlsson EA, Meliopoulos VA, Savage C et al (2015) Visualizing real-time influenza virus infection, transmission and protection in ferrets. Nat Commun 6:6378
Czako R, Vogel L, Lamirande EW et al (2017) In vivo imaging of Influenza virus infection in immunized mice. MBio 8(3):e00714
Harding AT, Heaton BE, Dumm RE et al (2017) Rationally designed Influenza virus vaccines that are antigenically stable during growth in eggs. MBio 8(3):e00669
DiPiazza A, Nogales A, Poulton N et al (2017) Pandemic 2009 H1N1 Influenza Venus reporter virus reveals broad diversity of MHC class II-positive antigen-bearing cells following infection in vivo. Sci Rep 7(1):10857
Breen M, Nogales A, Baker SF et al (2016) Replication-competent Influenza A and B viruses expressing a fluorescent dynamic timer protein for in vitro and in vivo studies. PLoS One 11(1):e0147723
Nogales A, Ávila-Pérez G, Rangel-Moreno J et al (2019) A novel fluorescent and bioluminescent Bi-Reporter influenza A virus (BIRFLU) to evaluate viral infections. J Virol 93:e00032
Nogales A, Rodriguez-Sanchez I, Monte K et al (2016) Replication-competent fluorescent-expressing influenza B virus. Virus Res 213:69–81
Reale MA, Manheimer AJ, Moran TM et al (1986) Characterization of monoclonal antibodies specific for sequential influenza A/PR/8/34 virus variants. J Immunol 137(4):1352–1358
Martinez-Sobrido L, Garcia-Sastre A (2010) Generation of recombinant influenza virus from plasmid DNA. J Vis Exp (42):2057
Wang Z, Duke GM (2007) Cloning of the canine RNA polymerase I promoter and establishment of reverse genetics for influenza A and B in MDCK cells. Virol J 4:102
Lu G, He D, Wang Z et al (2016) Cloning the Horse RNA polymerase I promoter and its application to studying Influenza virus polymerase activity. Viruses 8(6):119
Zhang X, Curtiss R (2015) Efficient generation of influenza virus with a mouse RNA polymerase I-driven all-in-one plasmid. Virol J 12:95
Massin P, Rodrigues P, Marasescu M et al (2005) Cloning of the chicken RNA polymerase I promoter and use for reverse genetics of influenza A viruses in avian cells. J Virol 79(21):13811–13816
Fodor E, Devenish L, Engelhardt OG et al (1999) Rescue of influenza A virus from recombinant DNA. J Virol 73(11):9679–9682
Neumann G, Watanabe T, Ito H et al (1999) Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A 96(16):9345–9350
Neumann G, Fujii K, Kino Y et al (2005) An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proc Natl Acad Sci U S A 102(46):16825–16829
Hoffmann E, Neumann G, Kawaoka Y et al (2000) A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 97(11):6108–6113
Acknowledgments
Influenza research in the Martinez-Sobrido laboratory is currently supported by the NIAID RO1 grants AI141607, AI145332, and HL091968 and the Department of Defense (DoD) Peer Reviewed Medical Research Program (PRMRP) grant W81XWH1710168. This work was also partly funded by the Center for Research on Influenza Pathogenesis and Transmission (CRIPT), a NIAID-funded Center of Excellence for Influenza Research and Response (CEIRR, contract # 75N93021C00014).
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Chiem, K., Nogales, A., Martinez-Sobrido, L. (2022). Generation, Characterization, and Applications of Influenza A Reporter Viruses. In: Kim, SB. (eds) Bioluminescence. Methods in Molecular Biology, vol 2524. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2453-1_19
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2453-1_19
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2452-4
Online ISBN: 978-1-0716-2453-1
eBook Packages: Springer Protocols